½ÃÀ庸°í¼­
»óǰÄÚµå
1611416

¼¼°èÀÇ ¼ö¸é º¸Á¶ ½ÃÀå : Á¦Ç°º°, ¼ö¸éÀå¾Öº°, À¯Åë ä³Îº° ¿¹Ãø(2025-2030³â)

Sleep Aids Market by Product (Mattresses & Pillows, Medications, Sleep Apnea Devices), Sleep-Disorder (Insomnia, Narcolepsy, Restless Legs Syndrome), Distribution Channel - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼ö¸é º¸Á¶ ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 593¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 641¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.98%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 891¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ö¸é º¸Á¶ ½ÃÀå¿¡´Â °³ÀÎÀÌ ´õ ³ªÀº ¼ö¸éÀ» ¾òÀ» ¼ö ÀÖµµ·Ï ¼³°èµÈ ´Ù¾çÇÑ Á¦Ç°°ú ¼­ºñ½º°¡ Æ÷ÇԵ˴ϴÙ. ½º¸¶Æ® ¼ö¸é ¸¶½ºÅ©¿Í ¼ö¸é ¼ö¸é ÃßÀû ¾Û°ú °°Àº ÀåÄ¡°¡ Æ÷ÇԵ˴ϴÙ. ¼ö¸é º¸Á¶ÀÇ Çʿ伺Àº ºÒ¸éÁõ, ¼ö¸é ¹«È£Èí ÁõÈıº ¹× ±âŸ ¼ö¸éÀå¾Ö°¡ ½ºÆ®·¹½º°¡ ¸¹Àº ´«ºÎ½Å ¶óÀÌÇÁ ½ºÅ¸ÀÏ·Î ÀÎÇØ ¾ÇÈ­µÇ±â ¶§¹®ÀÔ´Ï´Ù. ±× ¿ëµµ´Â Çï ½ºÄÉ¾î ½Ã¼³, À£´Ï½º ¼¾ÅÍ, Áý¿¡¼­ÀÇ °³ÀÎ »ç¿ë µî ´Ù¹æ¸é¿¡ °ÉÄ£ ÃÖÁ¾ »ç¿ëÀÚ¿¡°Ô´Â ¼ö¸é ¹®Á¦¿¡ °í¹ÎÇÏ´Â ¼ºÀÎ, ÀÚ¿¬ÀûÀÎ ¼ö¸é ÀúÇÏ¿¡ Á÷¸éÇÏ´Â ³ëÀÎÃþ, ½ÉÁö¾î ½ºÅ©¸° ŸÀÓ¿¡ ¿µÇâÀ» ¹Þ´Â ½Ê´ë°¡ Æ÷ÇԵ˴ϴÙ. ·¹¸¶ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ´Â °ÍÀº ¼ö¸éÀÇ Á߿伺¿¡ ´ëÇÑ ÀǽÄÀÇ ³ô¾Æ, ¼ö¸éÀå¾ÖÀÇ ¹ß»ý·üÀÇ »ó½Â, ¼ö¸é ±â¼úÀÇ Áøº¸ÀÔ´Ï´Ù. Ȧ¸®½ºÆ½ °Ç°­¹ý¿¡ ´ëÇÑ ±¹°¡ ½Ã ¹ßÀ» ¹Ý¿µÇϰí Çãºê º¸ÃæÁ¦ ¹× µðÁöÅÐ Ä¡·áÁ¦¿Í °°Àº ÀÚ¿¬ÀûÀÌ°í ´ëüÀûÀÎ ¼ö¸é ¼Ö·ç¼Ç¿¡ Å« ±âȸ°¡ ÀÖ½À´Ï´Ù. ½ÃÀåÀº ÀǾàǰÀÇ ¾ö°ÝÇÑ ±ÔÁ¦, »ç¿ëÀÚ ¿ä±¸ÀÇ ´Ù¾ç¼º, ¸í»ó ¹× ¿ä°¡¿Í °°Àº ÀüÅëÀûÀÎ ½À°ü°úÀÇ °æÀï°ú °°Àº °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. À» Ȱ¿ëÇÑ °³ÀÎÈ­ ¼ö¸é ¼Ö·ç¼Ç, ¿©·¯ °Ç°­ ÁöÇ¥ µ¥ÀÌÅ͸¦ °áÇÕÇÑ ÅëÇÕ ¾ÛÀ» Æ÷ÇÔÇÑ Çõ½ÅÀº Àͼ÷ÇÕ´Ï´Ù.¿¡ ´ëÇÑ °­ÇÑ ¼±È£µµ¸¦ Ư¡À¸·Î ÇÕ´Ï´Ù.ÀÌ ÁøÈ­ÇÏ´Â »óȲÀ» Ȱ¿ëÇϱâ À§ÇØ ±â¾÷Àº ÀÇ·á¿ë ¹× ºñÀÇ·á¿ë ¼ö¸é °³¼± ¼Ö·ç¼ÇÀ» ¿ä±¸ÇÏ´Â ´Ù¾çÇÑ ¼ÒºñÀÚÃþ¿¡ ´ëÀÀÇÏ´Â ´Ù¿ëµµ Á¦Ç° ¶óÀÎ ±¸Ãà¿¡ ÁÖ·ÂÇØ¾ßÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 593¾ï 2,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 641¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 891¾ï 1,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 5.98%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¼ö¸é º¸Á¶ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¼ö¸é º¸Á¶ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. È­ ¹× »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ´Ù¾çÇÑ ¼ö¸é »óÅÂÀÇ Ä¡·á, Áø´Ü ¿ä±¸ Áõ°¡
    • ¼ö¸éÀå¾Ö¿¡ ´ëÇÑ »ç¶÷µéÀÇ ÀǽÄÀÇ °íÁ¶
    • ¿þ¾î·¯ºí ¼¾¼­¿Í Æ®·¡Å· µð¹ÙÀ̽ºÀÇ ¼ö¿ë È®´ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼ö¸é º¸Á¶ ÀåÄ¡ÀÇ ºÎÀûÀýÇÑ Ä¶¸®ºê·¹À̼Ç
  • ½ÃÀå ±âȸ
    • ¼ö¸é º¸Á¶ ±â±â¿¡ À־ÀÇ ½Å±â¼úÀÇ ÀÎÆ®·Î´ö¼Ç
    • °Å´ëÇÑ ¼ö¸éº¸Á¶Á¦ ÀÔÂûÀ» À§ÇÑ ¿¬±¸°³¹ß(R&D)¿¡ ´ëÇÑ Á¤ºÎÀÚ±Ý Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • Çã°¡¸¦ À§ÇÑ ÀûÀýÇÑ ¼­·ùÀÇ ºÎÁ·

Porter's Five Forces : ¼ö¸é º¸Á¶ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ¼ö¸é º¸Á¶ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¼ö¸é º¸Á¶ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¼ö¸é º¸Á¶ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¼ö¸é º¸Á¶ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¼ö¸é º¸Á¶ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Positioning Matrix ¼ö¸é º¸Á¶ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Positioning Matrix´Â ¼ö¸é º¸Á¶ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ¼ö¸é º¸Á¶ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¼ö¸é º¸Á¶ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ´Ù¾çÇÑ ¼ö¸éÀå¾ÖÀÇ Ä¡·á¿Í Áø´ÜÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ´Ù
      • ¼ö¸éÀå¾Ö¿¡ ´ëÇÑ ±¹¹ÎÀÇ ÀǽÄÀÇ °íÁ¶
      • ¿þ¾î·¯ºí ¼¾¼­¿Í ÃßÀû µð¹ÙÀ̽ºÀÇ º¸±Þ È®´ë
    • ¾ïÁ¦¿äÀÎ
      • ¼ö¸é º¸Á¶ ÀåÄ¡ÀÇ ºÎÀûÀýÇÑ Á¶Á¤
    • ±âȸ
      • ¼ö¸é º¸Á¶¿¡ À־ÀÇ ½Å±â¼úÀÇ ÀÎÆ®·Î´ö¼Ç
      • ¿¬±¸°³¹ß(R&D)¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áõ°¡°¡ °Å¾×ÀÇ ÀÔÂûÀ» ÃÊ·¡Çϰí ÀÖ´Â ¼ö¸é º¸Á¶
    • °úÁ¦
      • Çã°¡ ¶óÀ̼±½º¿¡ ÇÊ¿äÇÑ ÀûÀýÇÑ ¹®¼­°¡ ¾ø½À´Ï´Ù
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¼ö¸é º¸Á¶¾à ½ÃÀå : Á¦Ç°º°

  • ¸ÅÆ®¸®½º¿Í º£°³
  • ÀǾàǰ
    • Çãºê ¾à
    • ½ÃÆÇ¾à
    • 󹿾à
  • ¼ö¸é ¹«È£Èí ÁõÈıº¿ë ÀåÄ¡
    • ÀûÀÀÇü ¼­º¸ ÀΰøÈ£Èí±â(ASV)
    • ÆäÀÌ¼È ÀÎÅÍÆäÀ̽º
    • ±¸°­ ÀåÄ¡
    • ±âµµ ¾ç¾Ð(PAP) ÀåÄ¡

Á¦7Àå ¼ö¸é º¸Á¶ ½ÃÀå ¼ö¸éÀå¾Ö

  • ºÒ¸éÁõ
  • ³ª·çÄÚ·¾½Ã
  • ¹«ÁÁî ´Ù¸® ÁõÈıº
  • ¼ö¸é½Ã ¹«È£ÈíÁõÈıº
  • À¯¸ÞÀ¯º´

Á¦8Àå ¼ö¸é º¸Á¶¾à ½ÃÀå : À¯Åë ä³Îº°

  • ¾à±¹
  • ÀüÀÚ»ó°Å·¡
  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¼ö¸é º¸Á¶ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼ö¸é º¸Á¶ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¼ö¸é º¸Á¶ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Apnea Sciences Corporation
  • Boehringer Ingelheim International GmbH
  • Cadwell Industries Inc.
  • Cleveland Medical Devices Inc.
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc.
  • Eisai Co. Ltd.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Koninklijke Philips NV
  • Merck and Co. Inc.
  • Natus Medical Inc.
  • Nihon Kohden Corporation
  • Pfizer Inc.
  • ResMed Inc.
  • Sanofi SA
BJH 24.12.24

The Sleep Aids Market was valued at USD 59.32 billion in 2023, expected to reach USD 64.15 billion in 2024, and is projected to grow at a CAGR of 5.98%, to USD 89.11 billion by 2030.

The sleep aids market encompasses a variety of products and services designed to help individuals achieve better sleep. This category includes pharmaceuticals like sedatives and hypnotics, over-the-counter remedies such as melatonin supplements, and devices like smart sleep masks and sleep tracking apps. The necessity for sleep aids arises from the prevalent issues of insomnia, sleep apnea, and other sleep disorders exacerbated by increasingly stressful and fast-paced lifestyles. Their application spans healthcare facilities, wellness centers, and individual use at home. End users include adults struggling with sleep problems, older demographics facing natural sleep decline, and even teenagers affected by screen time. Market growth is driven by increasing awareness of the importance of sleep, rising incidence of sleep disorders, and advancements in sleep technology. However, it's also influenced by the stigma of dependence on sleep medications and concerns about side effects. A significant opportunity lies in natural and alternative sleep solutions like herbal supplements and digital therapeutics, reflecting a public shift toward holistic health practices. Recommendations include investing in research and development of non-addictive sleep aids and user-friendly sleep technology. The market faces challenges such as stringent regulations in pharmaceuticals, variability in user needs, and competition from traditional practices like meditation and yoga. Innovation is ripe in biosensors for more accurate sleep tracking, AI-driven personalized sleep solutions, and integrative apps that combine data from multiple health metrics. The sleep aids market is dynamic, characterized by rapid technological advancements and a strong preference for safe, effective solutions that fit seamlessly into daily life. To capitalize on this evolving landscape, companies should focus on building versatile product lines that cater to a diverse consumer base seeking both medical and non-medical sleep improvement solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 59.32 billion
Estimated Year [2024] USD 64.15 billion
Forecast Year [2030] USD 89.11 billion
CAGR (%) 5.98%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sleep Aids Market

The Sleep Aids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for treating & diagnosing different forms of sleep conditions
    • Rising public awareness of the sleep disorders
    • Growing acceptance of wearable sensors and tracking devices
  • Market Restraints
    • Inappropriate calibration of devices of sleeping aids
  • Market Opportunities
    • Introduction of novel technologies in sleeping aids
    • Growing government funding for research & development (R&D) to bid huge sleep aids
  • Market Challenges
    • Absence of appropriate documents for the permitting license

Porter's Five Forces: A Strategic Tool for Navigating the Sleep Aids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sleep Aids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sleep Aids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sleep Aids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sleep Aids Market

A detailed market share analysis in the Sleep Aids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sleep Aids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sleep Aids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sleep Aids Market

A strategic analysis of the Sleep Aids Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sleep Aids Market, highlighting leading vendors and their innovative profiles. These include Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Industries Inc., Cleveland Medical Devices Inc., Compumedics Limited, Drive DeVilbiss Healthcare Inc., Eisai Co., Ltd., Fisher & Paykel Healthcare Corp. Ltd., Koninklijke Philips N. V., Merck and Co. Inc., Natus Medical Inc., Nihon Kohden Corporation, Pfizer Inc., ResMed Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Sleep Aids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Mattresses & Pillows, Medications, and Sleep Apnea Devices. The Medications is further studied across Herbal Drugs, OTC Drugs, and Prescription-Based Drugs. The Sleep Apnea Devices is further studied across Adaptive Servo-Ventilators (ASVs), Facial Interfaces, Oral Appliances, and Positive Airway Pressure (PAP) Devices.
  • Based on Sleep-Disorder, market is studied across Insomnia, Narcolepsy, Restless Legs Syndrome, Sleep Apnea, and Sleep Walking.
  • Based on Distribution Channel, market is studied across Drug Stores, E-Commerce, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for treating & diagnosing different forms of sleep conditions
      • 5.1.1.2. Rising public awareness of the sleep disorders
      • 5.1.1.3. Growing acceptance of wearable sensors and tracking devices
    • 5.1.2. Restraints
      • 5.1.2.1. Inappropriate calibration of devices of sleeping aids
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of novel technologies in sleeping aids
      • 5.1.3.2. Growing government funding for research & development (R&D) to bid huge sleep aids
    • 5.1.4. Challenges
      • 5.1.4.1. Absence of appropriate documents for the permitting license
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sleep Aids Market, by Product

  • 6.1. Introduction
  • 6.2. Mattresses & Pillows
  • 6.3. Medications
    • 6.3.1. Herbal Drugs
    • 6.3.2. OTC Drugs
    • 6.3.3. Prescription-Based Drugs
  • 6.4. Sleep Apnea Devices
    • 6.4.1. Adaptive Servo-Ventilators (ASVs)
    • 6.4.2. Facial Interfaces
    • 6.4.3. Oral Appliances
    • 6.4.4. Positive Airway Pressure (PAP) Devices

7. Sleep Aids Market, by Sleep-Disorder

  • 7.1. Introduction
  • 7.2. Insomnia
  • 7.3. Narcolepsy
  • 7.4. Restless Legs Syndrome
  • 7.5. Sleep Apnea
  • 7.6. Sleep Walking

8. Sleep Aids Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. E-Commerce
  • 8.4. Hospital Pharmacies
  • 8.5. Retail Pharmacies

9. Americas Sleep Aids Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Sleep Aids Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Sleep Aids Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apnea Sciences Corporation
  • 2. Boehringer Ingelheim International GmbH
  • 3. Cadwell Industries Inc.
  • 4. Cleveland Medical Devices Inc.
  • 5. Compumedics Limited
  • 6. Drive DeVilbiss Healthcare Inc.
  • 7. Eisai Co., Ltd.
  • 8. Fisher & Paykel Healthcare Corp. Ltd.
  • 9. Koninklijke Philips N. V.
  • 10. Merck and Co. Inc.
  • 11. Natus Medical Inc.
  • 12. Nihon Kohden Corporation
  • 13. Pfizer Inc.
  • 14. ResMed Inc.
  • 15. Sanofi S.A.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦